MTCR News

In the busiest week yet for the 2020 IPO market, 15 IPOs raised $8.7 billion. Snowflake (SNOW) took the spotlight, completing the largest software IPO ever and bagging the biggest billion-dollar pop in two decades. Eight SPACs joined the week’s diverse group of IPOs. The year’s largest IPO to date, Snowflake (SNOW) priced above...read more

Metacrine, a Phase 1 biotech developing FXR agonist therapies for NASH, raised $85 million by offering 6.5 million shares at $13, within the range of $12 to $14. At pricing, the company commands a fully diluted market value of $364 million. Metacrine plans to list on the Nasdaq under the symbol MTCR. Jefferies, Evercore ISI and RBC Capital Markets acted as lead managers on...read more

Updated Monday, 9/14. The post-Labor Day IPO frenzy is here as 14 IPOs plan to raise $7.8 billion in the coming week, led by cloud data unicorn Snowflake (SNOW). It is expected to be the biggest week for the IPO market by proceeds since May 2019, when Uber went public, and the most deals in a week since 2014. The largest deal of the...read more

Metacrine, a Phase 1 biotech developing FXR agonist therapies for NASH, announced terms for its IPO on Wednesday. The San Diego, CA-based company plans to raise $85 million by offering 6.5 million shares at a price range of $12 to $14. At the midpoint of the proposed range, Metacrine would command a fully diluted market value of $364 million. The company's lead candidate,...read more